Dmitry Balyasny’s Trillium Therapeutics Inc. TRIL Stock Holding History

Dmitry Balyasny’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-697,100	Closed	-$12.2M	–	2771
2021 Q3	$12.2M	Buy	+697,100	New	+$8.14M	0.05%	495

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Dmitry Balyasny's TRIL Position: Q4 2021 in Review

Dmitry Balyasny sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 225,000 shares — an estimated $3.95M sold.

Dmitry Balyasny first reported a position in TRIL in Q1 2020 and held it in 3 quarters. The position peaked at $3.95M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Dmitry Balyasny reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Dmitry Balyasny sold 225,000 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $3.95M.
Dmitry Balyasny first reported a position in Trillium Therapeutics Inc. in Q1 2020 and held it in 3 quarters.
Dmitry Balyasny's Trillium Therapeutics Inc. position peaked at $3.95M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Balyasny Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.